Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: Efficacy and tolerability in phase II clinical trials

Antiviral Therapy

Volumn 7, Issue 1, 2002, Pages 53-65

  Hayden, Frederick G ^a   Coats, Teresa ^b   Kim, Kenneth ^c   Hassman, Howard A ^d   Blatter, Mark M ^e   Zhang, Bing ^f   Liu, Siyu ^f  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Central Austin Internists   (United States)

^c Allergy Asthma Et Resp Care Center   (United States)

^d Comprehensive Clinical Research ^*  (United States)

^e Primary Physicians Research   (United States)

^f ViroPharma Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PLECONARIL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 2 CLINICAL TRIAL; PICORNAVIRUS; PICORNAVIRUS INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RHINORRHEA; SLEEP DISORDER; TABLET; TACHYCARDIA; VERTIGO;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OXADIAZOLES; PICORNAVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; VIRUS SHEDDING;

EID: 0036523703     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rueckert RR. Picornaviridae and their replication. In Fundamental Virology, 2nd edn 1991; pp. 409-450. Edited by BN Fields, DM Knipe, RM Chanock, et al.; New York: Raven Press.
2. Arruda E, Pitkaranta A, Witek TJ, Doyle CA & Hayden FG. Frequency and natural history of rhinovirus infections in adults during autumn. Journal of Clinical Microbiology 1997; 35:2864-2868.
3. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, Blomqvist S, Hyypia T & Arstila P. Viruses and bacteria in the etiology of the common cold. Journal of Clinical Microbiology 1998; 36: 539-542.
4. Chonmaitree T & Mann L. Respiratory Infections. In Human Enterovirus Infections, 1995; pp. 255. Edited by HA Rotbart. Washington, D.C.: American Society of Microbiology.
5. National Institute of Allergy and Infectious Diseases. Fact Sheet: The common cold. National Institutes of Health. 1998.
6. Hendley JO. Clinical virology of rhinoviruses. Advances in Virus Research 1999; 54:453-466.
7. Pitkaranta A, Jero J, Arruda E, Virolainen A & Hayden FG. Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion. Journal of Pediatrics 1998; 133:390-394.
8. Pitkaranta A, Virolainen A, Jero J, Arruda E & Hayden FG. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcription polymerase chain reaction. Pediatrics 1998; 102:291-295.
9. Pitkaranta A, Arruda E, Malmberg H & Hayden FG. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. Journal of Clinical Microbiology 1997; 35:1791-1793.
10. Nicholson KG, Kent J & Ireland DC. Respiratory viruses and exacerbations of asthma in adults. British Medical Journal 1993; 307:982-986.
11. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, Cunningham A, Robinson BS, Myint SH, Ward ME, Tyrrell DAJ & Holgate ST. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. American Journal of Respiratory and Critical Care Medicine 1996; 154:654-660.
12. Couch RB, Englund JA & Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. The American Journal of Medicine 1997; 102 (Suppl. 3A):2-9.
13. Gonzales R, Steiner JF & Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. Journal of the American Medical Association 1997; 278:901-904.
14. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR & Sande MA. Principles of appropriate antibiotic use for treatment of acute respiratory tract . infections in adults: background, specific aims, and methods. Annals of Internal Medicine 2001; 134:479-486.
15. Hadfield T, Diana GD & Rossmann MG. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16. Proceedings of the National Academy of Sciences of the USA 1999; 96:14730-14735.
16. Diana GD & Pevear DC. Antipicornavirus drugs: current status. Antiviral Chemistry & Chemotherapy 1997; 8:401-408.
17. McKinlay MA, Pevear DC & Rossmann MG. Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Annual Review of Microbiology 1992; 46:635-654.
18. Pevear DC, Tull TM, Seipel ME & Groarke JM. Activity of pleconaril against enteroviruses. Antimicrobial Agents and Chemotherapy 1999; 43:2109-2115.
19. Pevear DC. Antiviral therapy for picornavirus infections: pleconaril. 15th Annual Clinical Virology Symposium, Clearwater Beach, Florida, 9-12 May 1999.
20. Schiff GM & Sherwood JR. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. The Journal of Infectious Diseases 2000; 181:20-26.
21. Hayden FG, Hassman HA, Coats T, Menendez R & Bock T. Pleconaril treatment shortens duration of picornavirus respiratory illness in adults. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 26-29 September 1999, Abstract LB-3.
22. Hayden FG, Kim K, Coats T, Blatter M & Drehobl M. Pleconaril treatment shortens duration of picornaviral upper respiratory illness in adults. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17-20 September 2000, Abstract 1161.
23. Arruda E, Crump C, Rollins BS, Ohlin A & Hayden FG. Comparative susceptibility of human embryonic fibroblasts and HeLa cells for isolation of human rhinoviruses. Journal of Clinical Microbiology 1996; 34:1277-1279.
24. Kaplan EL & Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53:457-481.
25. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Statistics in Medicine 1982; 1:121-129.
26. Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, Winther B & Hayden FG. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. Journal of the American Medical Association 1999; 281:1797-1804.
27. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P & Mills RG. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. Journal of the American Medical Association 2000; 283:1057-1059.